Clinical Research


The Facts About Erectile Dysfunction

  • Viagra, Cialis, and Levitra had total revenues of $4 billion in 2012 for their respective companies, despite the fact that these medications only help half of all men and can have very unpleasant and potentially dangerous side effects.
  • Many men with mild ED, or even some with no ED symptoms at all, take these medications simply as supplements to ensure strong sexual performance.
  • Men with severe ED are candidates for micro-penile injections comprised of three or four vasodilators. These medications have no side effects as compared to the oral varieties.
    There is now a potential cure available. Our revolutionary Acoustic Wave Therapy Protocol uses acoustical pulse waves to open existing blood vessels, grow new blood vessels, and stimulate stem cells to grow new erectile tissue (corpus cavernosum) in the penis.
  • Depending on a man’s overall health and preexisting conditions, this noninvasive treatment option will greatly improve erectile dysfunction and performance.
  • Independent, published research papers have proven its safety and efficacy, with 86% of men saying they would recommend it to a friend.
  • We believe that this could actually roll back the clock for most men, allowing men of ages up to 80 — or even 90 — to perform as they did in their more virile years.


Clinical Research

Shockwave treatment of erectile dysfunction

LI-ESWT is a revolutionary treatment of ED, and probably possesses unprecedented qualities that can rehabilitate erectile tissue. The clinical improvement in subjective erectile function together with the significant improvement in penile hemodynamics following LI-ESWT confirm that LI-ESWT has unique properties that may create a new standard of care for men with ED. LI-ESWT is both feasible and tolerable and without any adverse or unwanted effects. Its main advantage is its ability to improve and potentially restore erectile function in men with ED without additional pharmacotherapy. Hence, LI-ESWT is an appealing addition to the armamentarium of existing treatment options for ED. In the near future, we hope that LI-ESWT will be used for the long-term clinical management of ED either as an alternative or as an enhancer to the current treatments of ED.

– NCBI & US National Library of Medicine, & National Institutes of Health

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial

– International Journal of Andrology, 2012

Low-intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population

– The Canadian Journal of Urology; 22(1); February 2015

Efficiency Assessment of Shock Wave Therapy in Patients with Pelvic Pain Employing Harmonic Analysis of Penile Bioimpedance

  – Bulletin of Experimental Biology and Medicine, Vol. 155, No. 2, June, 2013 METHODS

Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study

– International Journal of Impotence Research (2014)

Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis

– 2016 European Association of Urology. Published by Elsevier B.V.

Low Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapy

– 2011 International Society for Sexual Medicine

Can Low Intensity Extracorporeal Shockwave Therapy Improve
Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction

– April 16, 2010 European Urology Vardi – Extracorporeal shock wave therapy

Our Experience on the Association of a New Physical and Medical Therapy in Patients Suffering from Induratio penis plastica

– February 10, 1999 European Urology Mirone – Erectile Dysfunction

Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction

– International Journal of Urology (2016)

Peyronie’s disease the Plymouth experience of extracorporeal shockwave treatment

– 2001 BJU International 849

Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study


Therapeutic advances in the treatment of Peyronie’s disease

– © 2015 American Society of Andrology and European Academy of Andrology

Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial

– 2015 The Authors – BJU International © 2015 BJU International

Men’s Power-Pressure Wave Erectile Regeneration-Therapy


– Conclusion: The early experience of LISWT has shown an improvement in the sexual function of patients and a treatment regimen of two treatments per week for three weeks appears optimal.

Our Locations

Choose your preferred location